We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Libido Drug Vyleesi Approved to Treat Hypoactive Sexual Desire in Women

News   Jun 27, 2019 | Original story from the FDA

 
New Libido Drug Vyleesi Approved to Treat Hypoactive Sexual Desire in Women

Credit: AMAG Pharmaceuticals

 
 
Advertisement
 

RELATED ARTICLES

Animal Studies Suggest Lithium Can Reduce Amyloid's Impact on the Brain

News

Researchers have discovered that, whilst amyloid plaque formation directly causes brain tissue loss in animal models, lithium can reduce the life-shortening effects of this loss.

READ MORE

Novel Target for a Type of Pediatric Brain Tumor Identified

News

Researchers have found that the ABCC4 transporter is critical to the SHH signaling pathway in the brain tumor medulloblastoma – the most common malignant pediatric brain tumor.

READ MORE

A New Tool for Regulating Reactions in Microreactors

News

A team has developed a method for assembling hanging droplets that could assist chemical reactions in extremely small – less than 1 millimeter – spaces. This new method has potential to be applied to drug manufacturing.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE